Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study

BACKGROUND: Ischemic heart failure (IHF) has a poor prognosis in spite of optimal therapy. We have established a new allogeneic Cardiology Stem Cell Centre adipose-derived stromal cell (CSCC_ASC) product from healthy donors. It is produced without animal products, in closed bioreactor systems and cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kastrup, Jens, Schou, Morten, Gustafsson, Ida, Nielsen, Olav W., Møgelvang, Rasmus, Kofoed, Klaus F., Kragelund, Charlotte, Hove, Jens Dahlgaard, Fabricius-Bjerre, Andreas, Heitman, Merete, Haack-Sørensen, Mandana, Lund, Lisbeth Drozd, Johansen, Ellen Mønsted, Qayyum, Abbas Ali, Mathiasen, Anders Bruun, Ekblond, Annette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625749/
https://www.ncbi.nlm.nih.gov/pubmed/29056973
http://dx.doi.org/10.1155/2017/8506370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625749/
https://www.ncbi.nlm.nih.gov/pubmed/29056973
http://dx.doi.org/10.1155/2017/8506370

Ejemplares similares